+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bevantolol Market by Formulation (Intravenous Forms, Oral Tablets), Application (Angina Pectoris, Hypertension), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968131
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bevantolol Market grew from USD 466.83 million in 2023 to USD 486.34 million in 2024. It is expected to continue growing at a CAGR of 4.30%, reaching USD 627.25 million by 2030.

Bevantolol works by blocking specific receptors in the heart, which helps slow down the heart rate and reduce blood pressure. This action makes it easier for the heart to pump blood and can help improve heart function. The increasing global incidence of conditions such as hypertension accelerated the demand for bevantolol. The robustness of healthcare systems and the availability of advanced medical facilities contribute to market growth. However, the presence of alternative and possibly more effective treatments could limit market share. Furthermore, ongoing innovations and clinical trials enhance efficacy and broaden the application range of bevantolol owing to market expansion. Developing tailored formulations that cater to specific patient demographics and subgroups poses significant opportunities.

Regional Insights

In the American region, there is a high prevalence of cardiovascular diseases, which drives the demand for effective treatments such as bevantolol. The market is well-regulated by the FDA, ensuring that medications in the market are safe and effective. Consumer preference leans towards drugs with fewer side effects and strong efficacy, which influences purchasing behaviors. EU countries exhibit a strong healthcare infrastructure and a high awareness of cardiovascular health. The European Medicines Agency (EMA) plays a critical role in regulating and approving drugs. Markets here are driven by innovation, and consumers show a high preference for clinically validated and cost-effective medications. The market is expanding slower due to varying healthcare standards and economic disparities across countries. There is an increasing awareness and demand for modern therapeutic options, although regulatory frameworks are less uniform. The APAC has seen significant investments in healthcare infrastructure and a surge in local pharmaceutical manufacturing. The regulatory policies ensure that only approved drugs are available in the market. Consumer behavior is notably influenced by governmental healthcare reforms and local production.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Bevantolol Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of hypertension and heart-related diseases
  • Improving healthcare infrastructure and increased healthcare spending

Market Restraints

  • Presence of numerous cost-effective alternatives for bevantolol

Market Opportunities

  • Innovations in drug delivery systems and formulations
  • Ongoing research to explore the use of bevantolol in combination with other drugs

Market Challenges

  • Side effects and lengthy approval process for bevantolol

Market Segmentation Analysis

  • Formulation: Growing preference for oral tablets due to convenience and cost-effectiveness
  • Application: Rising prevalence of hypertension accelerating demand for bevantolol

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bevantolol Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bevantolol Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Bevantolol Hydrochloride Demonstrates Efficacy and Tolerability in Reducing Chorea Symptoms in Huntington’s Disease Patients

A study involving 32 participants with Huntington’s disease evaluated the efficacy of bevantolol hydrochloride (SOM3355) across a double-blind, placebo-controlled crossover trial. The research incorporated two dosage levels of the medication, 100 mg, and 200 mg, administered twice daily across four 6-week phases. Results indicated that the treatment is well tolerated and significantly reduces chorea, as confirmed by an improvement of at least two points in the total maximal chorea score compared to the placebo period.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bevantolol Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bevantolol Market, highlighting leading vendors and their innovative profiles. These include BOC Sciences, Career Henan Chemical Co. Ltd., Cayman Chemical Company, Chongqing Chemdad Co., Ltd., Clinivex, Conier Chem & Pharma Limited, CP Lab Safety, Cymit Química S.L., Hebei Guanlang Biotechnology Co., Ltd., Hebei Mojin Biotechnology Co., Ltd., Ipca Laboratories Ltd., Lab Pro Inc., Merck KGaA, Sahinler Chemistry, Simson Pharma Limited, Som Biotech, Thermo Fisher Scientific Inc., TNJ Chemical Industry Co.,Ltd., Tokyo Chemical Industry Co., Ltd., and VWR International by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Bevantolol Market to forecast the revenues and analyze trends in each of the following sub-markets:

Formulation

  • Intravenous Forms
  • Oral Tablets

Application

  • Angina Pectoris
  • Hypertension
  • Distribution Channel

Offline

  • Hospitals
  • Retail Pharmacies
  • Online

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of hypertension and heart-related diseases
5.1.1.2. Improving healthcare infrastructure and increased healthcare spending
5.1.2. Restraints
5.1.2.1. Presence of numerous cost-effective alternatives for bevantolol
5.1.3. Opportunities
5.1.3.1. Innovations in drug delivery systems and formulations
5.1.3.2. Ongoing research to explore the use of bevantolol in combination with other drugs
5.1.4. Challenges
5.1.4.1. Side effects and lengthy approval process for bevantolol
5.2. Market Segmentation Analysis
5.2.1. Formulation: Growing preference for oral tablets due to convenience and cost-effectiveness
5.2.2. Application: Rising prevalence of hypertension accelerating demand for bevantolol
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Bevantolol Market, by Formulation
6.1. Introduction
6.2. Intravenous Forms
6.3. Oral Tablets
7. Bevantolol Market, by Application
7.1. Introduction
7.2. Angina Pectoris
7.3. Hypertension
8. Bevantolol Market, by Distribution Channel
8.1. Introduction
8.2. Offline
8.3. Online
9. Americas Bevantolol Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bevantolol Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bevantolol Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Bevantolol Hydrochloride Demonstrates Efficacy and Tolerability in Reducing Chorea Symptoms in Huntington’s Disease Patients
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. BEVANTOLOL MARKET RESEARCH PROCESS
FIGURE 2. BEVANTOLOL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BEVANTOLOL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BEVANTOLOL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BEVANTOLOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BEVANTOLOL MARKET DYNAMICS
FIGURE 7. GLOBAL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BEVANTOLOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BEVANTOLOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BEVANTOLOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BEVANTOLOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BEVANTOLOL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. BEVANTOLOL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BEVANTOLOL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BEVANTOLOL MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BEVANTOLOL MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BEVANTOLOL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BEVANTOLOL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BEVANTOLOL MARKET SIZE, BY INTRAVENOUS FORMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BEVANTOLOL MARKET SIZE, BY INTRAVENOUS FORMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BEVANTOLOL MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BEVANTOLOL MARKET SIZE, BY ORAL TABLETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BEVANTOLOL MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BEVANTOLOL MARKET SIZE, BY ANGINA PECTORIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BEVANTOLOL MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BEVANTOLOL MARKET SIZE, BY HYPERTENSION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BEVANTOLOL MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BEVANTOLOL MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BEVANTOLOL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BEVANTOLOL MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BEVANTOLOL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BEVANTOLOL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BEVANTOLOL MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BEVANTOLOL MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS BEVANTOLOL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS BEVANTOLOL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 57. CANADA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 58. CANADA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 59. CANADA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. CANADA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. CANADA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 64. CANADA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 65. MEXICO BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 66. MEXICO BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. MEXICO BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. MEXICO BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 70. MEXICO BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 71. MEXICO BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 72. MEXICO BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES BEVANTOLOL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES BEVANTOLOL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC BEVANTOLOL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 93. AUSTRALIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 94. AUSTRALIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 101. CHINA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 102. CHINA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 103. CHINA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. CHINA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. CHINA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 106. CHINA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 107. CHINA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 108. CHINA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 109. INDIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 110. INDIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 111. INDIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. INDIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. INDIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. INDIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. INDIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 116. INDIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 117. INDONESIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 118. INDONESIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 119. INDONESIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. INDONESIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 125. JAPAN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 126. JAPAN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 127. JAPAN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. JAPAN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. JAPAN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 130. JAPAN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 131. JAPAN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 132. JAPAN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 133. MALAYSIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 134. MALAYSIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 135. MALAYSIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. MALAYSIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 141. PHILIPPINES BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 142. PHILIPPINES BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 143. PHILIPPINES BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. PHILIPPINES BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 149. SINGAPORE BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 150. SINGAPORE BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 151. SINGAPORE BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. SINGAPORE BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 157. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 158. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 159. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 165. TAIWAN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 166. TAIWAN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 167. TAIWAN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. TAIWAN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 173. THAILAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 174. THAILAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 175. THAILAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. THAILAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. THAILAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 178. THAILAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 179. THAILAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 180. THAILAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 181. VIETNAM BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 182. VIETNAM BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 183. VIETNAM BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. VIETNAM BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BEVANTOLOL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 199. DENMARK BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 200. DENMARK BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 201. DENMARK BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. DENMARK BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. DENMARK BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 204. DENMARK BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 205. DENMARK BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 206. DENMARK BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 207. EGYPT BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 208. EGYPT BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 209. EGYPT BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. EGYPT BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. EGYPT BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. EGYPT BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. EGYPT BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 214. EGYPT BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 215. FINLAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 216. FINLAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 217. FINLAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. FINLAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. FINLAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 220. FINLAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 221. FINLAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 222. FINLAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 223. FRANCE BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 224. FRANCE BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 225. FRANCE BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. FRANCE BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. FRANCE BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 228. FRANCE BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 229. FRANCE BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 230. FRANCE BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 231. GERMANY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 232. GERMANY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 233. GERMANY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. GERMANY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. GERMANY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. GERMANY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. GERMANY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 238. GERMANY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 239. ISRAEL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 240. ISRAEL BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 241. ISRAEL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. ISRAEL BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 247. ITALY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 248. ITALY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 249. ITALY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. ITALY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. ITALY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 252. ITALY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 253. ITALY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 254. ITALY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 255. NETHERLANDS BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 256. NETHERLANDS BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 257. NETHERLANDS BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. NETHERLANDS BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 263. NIGERIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 264. NIGERIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 265. NIGERIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. NIGERIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 271. NORWAY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 272. NORWAY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 273. NORWAY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. NORWAY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. NORWAY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 276. NORWAY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 277. NORWAY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 278. NORWAY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 279. POLAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 280. POLAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 281. POLAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. POLAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. POLAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 284. POLAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 285. POLAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 286. POLAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 287. QATAR BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 288. QATAR BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 289. QATAR BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. QATAR BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. QATAR BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 292. QATAR BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 293. QATAR BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 294. QATAR BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 295. RUSSIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 296. RUSSIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 297. RUSSIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. RUSSIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 304. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 312. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 319. SPAIN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 320. SPAIN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 321. SPAIN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. SPAIN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. SPAIN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 324. SPAIN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 325. SPAIN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 326. SPAIN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 327. SWEDEN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 328. SWEDEN BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 329. SWEDEN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. SWEDEN BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 335. SWITZERLAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 336. SWITZERLAND BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 337. SWITZERLAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. SWITZERLAND BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 343. TURKEY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 344. TURKEY BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 345. TURKEY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. TURKEY BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. TURKEY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 348. TURKEY BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 349. TURKEY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 350. TURKEY BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 359. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
TABLE 360. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 362. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 364. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY OFFLINE, 2018-2023 (USD MILLION)
TABLE 366. UNITED KINGDOM BEVANTOLOL MARKET SIZE, BY OFFLINE, 2024-2030 (USD MILLION)
TABLE 367. BEVANTOLOL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 368. BEVANTOLOL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BOC Sciences
  • Career Henan Chemical Co. Ltd.
  • Cayman Chemical Company
  • Chongqing Chemdad Co., Ltd.
  • Clinivex
  • Conier Chem & Pharma Limited
  • CP Lab Safety
  • Cymit Química S.L.
  • Hebei Guanlang Biotechnology Co., Ltd.
  • Hebei Mojin Biotechnology Co., Ltd.
  • Ipca Laboratories Ltd.
  • Lab Pro Inc.
  • Merck KGaA
  • Sahinler Chemistry
  • Simson Pharma Limited
  • Som Biotech
  • Thermo Fisher Scientific Inc.
  • TNJ Chemical Industry Co.,Ltd.
  • Tokyo Chemical Industry Co., Ltd.
  • VWR International by Avantor, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 486.34 Million
Forecasted Market Value ( USD ) by 2030 $ 627.25 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal

Related Topics

Related Reports

Bevantolol (CAS 59170-23-9) Global Market Research Report 2024 - Product Image

Bevantolol (CAS 59170-23-9) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Cilazapril Market by Formulation (Cilazapril Hydrochloride, Cilazapril Monohydrate), Form (Capsules, Tablets), Application, Distribution Channel - Forecast 2024-2030 - Product Image

Global Cilazapril Market by Formulation (Cilazapril Hydrochloride, Cilazapril Monohydrate), Form (Capsules, Tablets), Application, Distribution Channel - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Global Hyperlipidemia Drugs Market by Drug Class (Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors), Route of Administration (Oral, Parenteral), Sales Channel - Forecast 2024-2030 - Product Image

Global Hyperlipidemia Drugs Market by Drug Class (Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors), Route of Administration (Oral, Parenteral), Sales Channel - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report by Drug Class (Diuretics, ACE Inhibitors), Type (Primary, Secondary), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report by Drug Class (Diuretics, ACE Inhibitors), Type (Primary, Secondary), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Heart Transplantation Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Immunosuppressants, Anti-infectives, Analgesics), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Bevantolol Market

Bevantolol is a beta-blocker drug used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. It works by blocking the action of certain natural substances in the body, such as epinephrine, that affect the heart and blood vessels. Bevantolol is usually taken orally, but can also be administered intravenously. It is generally well tolerated, with few side effects. Bevantolol is a widely used drug in the cardiovascular market, as it is effective in treating a variety of conditions. It is also relatively inexpensive, making it an attractive option for many patients. Additionally, it is available in both generic and brand-name formulations, allowing for greater access to the drug. In the Bevantolol market, some of the major players include Pfizer, Merck, Novartis, and Sanofi. Other companies such as Mylan, Teva, and Sun Pharmaceuticals also have a presence in the market. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.